These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19370719)

  • 1. Industrial R&D paradigm shift to vaccines.
    Maggon K
    Biotechnol J; 2009 Apr; 4(4):458-61. PubMed ID: 19370719
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

  • 4. Innovative drug R&D in China.
    Qi J; Wang Q; Yu Z; Chen X; Wang F
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract]   [Full Text] [Related]  

  • 5. An audience with...Marc Cluzel.
    Cluzel M
    Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 7. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 8. Merck opts for shake-up to clear drug pipeline.
    Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug research--a change of paradigms.
    Müllner S
    Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454
    [No Abstract]   [Full Text] [Related]  

  • 10. What drives operational performance in clinical R&D?
    Ringel M; Martin L; Hawkins C; Panier V; Denslow M; Buck L; Schulze U
    Nat Rev Drug Discov; 2016 Mar; 15(3):155-6. PubMed ID: 26846158
    [No Abstract]   [Full Text] [Related]  

  • 11. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 12. A changing drug supply.
    Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategic trends in the vaccine market.
    Kresse H; Shah M
    Nat Rev Drug Discov; 2010 Dec; 9(12):913-4. PubMed ID: 21119727
    [No Abstract]   [Full Text] [Related]  

  • 15. Brand-name drug companies fail to meet R&D commitments.
    Kondro W
    CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed scores for European research.
    Chipman A
    Nature; 2007 Nov; 450(7166):16-7. PubMed ID: 17972849
    [No Abstract]   [Full Text] [Related]  

  • 17. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 18. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 19. A place in the sun.
    Abbott A
    Nature; 2007 Mar; 446(7132):124-5. PubMed ID: 17344823
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of best investing in vaccines: the Health Technology Assessment approach.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Specchia ML; Nicolotti N; Ricciardi W
    Vaccine; 2008 Mar; 26(13):1609-10. PubMed ID: 18289744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.